PRECLINICAL STUDIES TO ASSESS ACUTE AND CHRONIC TOXICITIES OF A CANDIDATE DRUG BASED ON COMPLEMENT C3 NEODETERMINANT RECOMBINANT HUMANIZED ANTIBODY FOR TREATMENT OF TRAUMATIC BRAIN INJURIES

Autor: A.V. Petrov, M.S. Zakharov, N. P. Gorbunov, Pigareva Nv, S.V. Rodin, A.E. Krylova, I.V. Bendt, G.V. Aleksandrov, О.E. Khuttunen, A.V. Trofimov, A.V. Zhakhov, A.M. Ischenko, А.S. Kiryanova
Rok vydání: 2021
Předmět:
Zdroj: http://eng.biomos.ru/conference/articles.htm. 1:48-49
ISSN: 2312-640X
Popis: A drug based on complement C3 neodeterminant recombinant humanized antibody for the treatment of traumatic brain injuries belongs to the class III of low-risk drugs.
Databáze: OpenAIRE